CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale
- 4 Insider Changes in Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
- DEFA14A Proxy Proxy Materials
- SC 13D Stake Beneficial Ownership Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 4 Insider Changes in Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
Page 20 of 46 · 904 filings